Back
Seelos Therapeutics Vs. Moleculin Biotech Industry Stock Comparison
Sell
18
SEEL
Seelos Therapeutics
Last Price:
0.39
Seasonality Move:
30.44%
Sell
34
MBRX
Moleculin Biotech
Last Price:
2.90
Seasonality Move:
-7.93%
Sell
18
Seelos Therapeutics (SEEL)
is a Sell
Is Seelos Therapeutics a Buy, Sell or Hold?
- The current Seelos Therapeutics [SEEL] share price is $0.39. The Score for SEEL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- SEEL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy, Sell or Hold?
- The current Moleculin Biotech [MBRX] share price is $2.83. The Score for MBRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- MBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SEEL Stock Price Chart
What is Seelos Therapeutics's stock price today?
-
The Seelos Therapeutics share price today is $0.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing selling pressure, which indicates risk of future bearish movement.
MBRX Stock Price Chart
What is Moleculin Biotech's stock price today?
-
The Moleculin Biotech share price today is $2.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SEEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 24.51 | Sell |
| Chaikin Money Flow: | -37507 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 1.38) | Sell |
| Bollinger Bands (100): | (-0.11 - 1.87) | Sell |
MBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 56.85 | Buy |
| Chaikin Money Flow: | 15509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.43 - 2.73) | Buy |
| Bollinger Bands (100): | (2.18 - 3.32) | Buy |
SEEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.88 | Sell |
| 50-day SMA: | 1.35 | Sell |
| 200-day SMA: | 2.48 | Sell |
| 8-day EMA: | 0.64 | Sell |
| 20-day EMA: | 0.91 | Sell |
| 50-day EMA: | 1.13 | Sell |
| 200-day EMA: | 16.7 | Sell |
MBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.7 | Buy |
| 20-day SMA: | 2.58 | Buy |
| 50-day SMA: | 2.54 | Buy |
| 200-day SMA: | 4.28 | Sell |
| 8-day EMA: | 2.68 | Buy |
| 20-day EMA: | 2.61 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 4.31 | Sell |
Seelos Therapeutics Earnings Growth & SEEL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Moleculin Biotech Earnings Growth & MBRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Seelos Therapeutics Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Moleculin Biotech Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||